BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

267 related articles for article (PubMed ID: 37298160)

  • 21. Antibodies to beta2-glycoprotein I: a potential marker for clinical features of antiphospholipid antibody syndrome in patients with systemic lupus erythematosus.
    Sanfilippo SS; Khamashta MA; Atsumi T; Amengual O; Bertolaccini ML; D'Cruz D; Amft N; Swana GT; Hughes GR
    J Rheumatol; 1998 Nov; 25(11):2131-4. PubMed ID: 9818654
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The value of IgA antiphospholipid testing for diagnosis of antiphospholipid (Hughes) syndrome in systemic lupus erythematosus.
    Bertolaccini ML; Atsumi T; Escudero Contreras A; Khamashta MA; Hughes GR
    J Rheumatol; 2001 Dec; 28(12):2637-43. PubMed ID: 11764209
    [TBL] [Abstract][Full Text] [Related]  

  • 23. MHC studies of the primary antiphospholipid antibody syndrome and of antiphospholipid antibodies in systemic lupus erythematosus.
    Goldstein R; Moulds JM; Smith CD; Sengar DP
    J Rheumatol; 1996 Jul; 23(7):1173-9. PubMed ID: 8823688
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Non-thromboembolic risk in systemic lupus erythematosus associated with antiphospholipid syndrome.
    Deák M; Bocskai M; Burcsár S; Dányi O; Fekete Z; Kovács L
    Lupus; 2014 Aug; 23(9):913-8. PubMed ID: 24729279
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Study of antiphospholipid antibodies by enzyme immunoassay and chemiluminescent methods in patients with antiphospholipid syndrome and systemic lupus erythematosus (preliminary data).
    Cheldieva FA; Reshetnyak TM; Cherkasova MV; Lila AM
    Klin Lab Diagn; 2021 Sep; 66(9):546-551. PubMed ID: 34543533
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Clinical spectrum of males with primary antiphospholipid syndrome and systemic lupus erythematosus: a comparative study of 73 patients.
    Medina G; Vera-Lastra O; Barile L; Salas M; Jara LJ
    Lupus; 2004; 13(1):11-6. PubMed ID: 14870912
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The interplay between the antiphospholipid syndrome and systemic lupus erythematosus.
    Tincani A; Andreoli L; Chighizola C; Meroni PL
    Autoimmunity; 2009 May; 42(4):257-9. PubMed ID: 19811269
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Comparison of the primary and secondary antiphospholipid syndrome: a European Multicenter Study of 114 patients.
    Vianna JL; Khamashta MA; Ordi-Ros J; Font J; Cervera R; Lopez-Soto A; Tolosa C; Franz J; Selva A; Ingelmo M
    Am J Med; 1994 Jan; 96(1):3-9. PubMed ID: 8304360
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Galectin-9 is an easy to measure biomarker for the interferon signature in systemic lupus erythematosus and antiphospholipid syndrome.
    van den Hoogen LL; van Roon JAG; Mertens JS; Wienke J; Lopes AP; de Jager W; Rossato M; Pandit A; Wichers CGK; van Wijk F; Fritsch-Stork RDE; Radstake TRDJ
    Ann Rheum Dis; 2018 Dec; 77(12):1810-1814. PubMed ID: 30185417
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Classification of an intermediate group of patients with antiphospholipid syndrome and lupus-like disease: primary or secondary antiphospholipid syndrome?
    Weber M; Hayem G; De Bandt M; Seifert B; Palazzo E; Roux S; Kahn MF; Meyer O
    J Rheumatol; 1999 Oct; 26(10):2131-6. PubMed ID: 10529128
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Soluble adhesion molecules in antiphospholipid syndrome associated with systemic lupus erythematosus and in primary antiphospholipid syndrome].
    Aleksandrova EN; Novikov AA; Reshetniak TM; Kliukvina NG; Reshetniak DV; Samsonov MIu; Nasonov EL
    Ter Arkh; 2002; 74(5):23-7. PubMed ID: 12087900
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Cardiac dysfunction in patients with systemic lupus erythematosus and antiphospholipid syndrome.
    Paran D; Caspi D; Levartovsky D; Elkayam O; Kaufman I; Litinsky I; Keren G; Koifman B
    Ann Rheum Dis; 2007 Apr; 66(4):506-10. PubMed ID: 17079247
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Systemic lupus erythematosus and antiphospholipid syndrome].
    Gröne HJ
    Verh Dtsch Ges Pathol; 1996; 80():21-37. PubMed ID: 9065004
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Systemic lupus erythematosus and antiphospholipid syndrome].
    Gröne HJ
    Pathologe; 1996 Nov; 17(6):405-16. PubMed ID: 9082361
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Anti-chromatin antibodies in systemic lupus erythematosus: a useful marker for lupus nephropathy.
    Cervera R; Viñas O; Ramos-Casals M; Font J; García-Carrasco M; Sisó A; Ramírez F; Machuca Y; Vives J; Ingelmo M; Burlingame RW
    Ann Rheum Dis; 2003 May; 62(5):431-4. PubMed ID: 12695155
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Gene profiling reveals specific molecular pathways in the pathogenesis of atherosclerosis and cardiovascular disease in antiphospholipid syndrome, systemic lupus erythematosus and antiphospholipid syndrome with lupus.
    Perez-Sanchez C; Barbarroja N; Messineo S; Ruiz-Limon P; Rodriguez-Ariza A; Jimenez-Gomez Y; Khamashta MA; Collantes-Estevez E; Cuadrado MJ; Aguirre MA; Lopez-Pedrera C
    Ann Rheum Dis; 2015 Jul; 74(7):1441-9. PubMed ID: 24618261
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Antiphospholipid syndrome (APS) in patients with systemic lupus erythematosus (SLE) implies a more severe disease with more damage accrual and higher mortality.
    Riancho-Zarrabeitia L; Martínez-Taboada V; Rúa-Figueroa I; Alonso F; Galindo-Izquierdo M; Ovalles J; Olivé-Marqués A; Fernández-Nebro A; Calvo-Alén J; Menor-Almagro R; Tomero-Muriel E; Uriarte-Isacelaya E; Botenau A; Andres M; Freire-González M; Santos Soler G; Ruiz-Lucea E; Ibáñez-Barceló M; Castellví I; Galisteo C; Quevedo Vila V; Raya E; Narváez-García J; Expósito L; Hernández-Beriaín JA; Horcada L; Aurrecoechea E; Pego-Reigosa JM
    Lupus; 2020 Oct; 29(12):1556-1565. PubMed ID: 32807021
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Opposite Profiles of Complement in Antiphospholipid Syndrome (APS) and Systemic Lupus Erythematosus (SLE) Among Patients With Antiphospholipid Antibodies (aPL).
    Savelli SL; Roubey RAS; Kitzmiller KJ; Zhou D; Nagaraja HN; Mulvihill E; Barbar-Smiley F; Ardoin SP; Wu YL; Yu CY
    Front Immunol; 2019; 10():885. PubMed ID: 31134052
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Reduced circulating Tregs and positive pANCA were robustly associated with the occurrence of antiphospholipid syndrome in patients with systemic lupus erythematosus.
    Wang J; Guo HX; Cheng T; Shi L; Zhang SX; Li XF
    Lupus; 2023 May; 32(6):746-755. PubMed ID: 37051771
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Association between neutrophil extracellular traps (NETs) and thrombosis in antiphospholipid syndrome.
    Mazetto BM; Hounkpe BW; da Silva Saraiva S; Vieira-Damiani G; Dos Santos APR; Jacinto BC; Vaz CO; Mesquita GTV; Annichino-Bizzacchi JM; De Paula EV; Orsi FA
    Thromb Res; 2022 Jun; 214():132-137. PubMed ID: 35561448
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.